Evidence map›Paper›PMID 35579754›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Primary ambulatory thromboprophylaxis in patients with pancreatic cancer receiving chemotherapy: hope or hype?

Thura Win Htut, Kyaw Zin Thein, Kyaw Lwin Aung, Thein Hlaing Oo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thura Win HtutDepartment of Haematology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, UK.ORCID http://orcid.org/0000-0002-5508-1472
Kyaw Zin TheinDivision of Hematology and Medical Oncology, Oregon Health and Science University/Knight Cancer Institute, Portland, OR, USA.ORCID http://orcid.org/0000-0003-1518-1097
Kyaw Lwin AungDepartment of Oncology and Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin, TX, USA.ORCID http://orcid.org/0000-0001-9889-0379
Thein Hlaing OoSection of Thrombosis and Benign Hematology (Unit 1464), The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, USA. thoo@mdanderson.org.ORCID http://orcid.org/0000-0002-5201-731X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombosis is the second leading cause of death in cancer patients. Patients with pancreatic cancer (PC) have a very high risk of developing venous thromboembolism (VTE). Even though primary ambulatory thromboprophylaxis (PATP) could decrease this risk, there are uncertain issues with regard to the choice and dose of anticoagulants, duration of anticoagulant therapy, and patient selection criteria. In addition, the current practice guidelines on PATP in PC patients are equivocal. This review critically appraises the evidence on the use of PATP in PC patients receiving chemotherapy.

Indexed as

NeoplasmsPancreatic NeoplasmsThrombosisVenous ThromboembolismAnticoagulantsHumansAnticoagulantsChemotherapyPancreatic cancerPrimary ambulatory thromboprophylaxisRisk scoring systemsVenous thromboembolism

Identifiers

PMID35579754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.